Arkema reports higher third-quarter earnings and sales, confirms guidance

Arkema today reported a 6.4% increase in third-quarter group net income, to €116 million ($148.1 million), on 1.2% higher sales, at €1.6 billion, including a 2.8% contribution from the acquisitions of Hipro Polymers and Casda Biomaterials in China, and Seppic’s alcoxylates operation. This was offset by a 2.4% drop in volumes because of a slowdown in some end-markets in September, notably automotive and construction in Europe and photovoltaics in general. Prices declined 4.5%, mainly affecting acrylic acid and fluorinated gases, the company says...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers